Calidi Biotherapeutics (CLDI) Exchange Rate Effect (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted Exchange Rate Effect of $8000.0 for Q4 2025, down 50.0% on a QoQ basis from $16000.0 in Q4 2024, and down 50.0% year-over-year from $16000.0 in Q4 2024.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Exchange Rate Effect (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics has reported Exchange Rate Effect for 4 years, with the latest figure at $8000.0 in Q4 2025.
- On a quarterly basis, Exchange Rate Effect fell 50.0% year-over-year to $8000.0 in Q4 2025; TTM through Dec 2025 was -$9000.0, a 30.77% increase from a year earlier, with the FY2025 full-year figure at $14000.0, up 207.69% from the prior year.
- Exchange Rate Effect was $8000.0 for Q4 2025 at Calidi Biotherapeutics, down from $16000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $23000.0 in Q3 2023, with the low at -$33000.0 in Q3 2024.
- Average Exchange Rate Effect over 4 years is $875.0, with a median of $8000.0 recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect sank 337.5% in 2023, then soared 184.21% in 2024.
- Over 4 years, Exchange Rate Effect stood at $8000.0 in 2022, then tumbled by 337.5% to -$19000.0 in 2023, then jumped by 184.21% to $16000.0 in 2024, then slumped by 50.0% to $8000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $8000.0 (Q4 2025), $16000.0 (Q4 2024), and -$33000.0 (Q3 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | -1.83 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - | 6,000.00 |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.35 Bn | 55.72 Mn | -124,000.00 |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn | -300,000.00 |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn | -774,000.00 |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn | 1,000.00 |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.39 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.96 Bn | 1.79 Bn | 56.40 Mn | - |
| 10 | Calidi Biotherapeutics | 1.87 Mn | -2.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Sep 30, 2024 | -33,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | 17,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Dec 31, 2022 | 8,000.00 |